Filtered By:
Source: PM and R
This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 227 results found since Jan 2013.
Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study
Dextromethorphan 20 mg / quinidine 10 mg (DM/Q) was approved to treat pseudobulbar affect (PBA) based on phase 3 trials conducted in participants with amyotrophic lateral sclerosis or multiple sclerosis. PRISM II evaluated DM/Q effectiveness, safety, and tolerability for PBA following stroke, dementia, or traumatic brain injury (TBI).
Source: PM and R - February 22, 2018 Category: Rehabilitation Authors: Flora M. Hammond, William Sauve, Fred Ledon, Charles Davis, Andrea E. Formella Tags: Original Research Source Type: research
The Suicidal Outpatient: Balancing Autonomy, Trust, and Responsibilities
The intersection where mental health and rehabilitation care converge can raise ethical questions involving boundaries, duties, and perhaps more importantly, our role in recovery, adjustment, and flourishing. The patient with a stroke-related depression is one prototypical example. We know that damage to specific parts of the brain can cause depressive symptomatology as well as the fact that the adjustment process during rehabilitation itself can impact well-being and a sense of self-efficacy. In this column, we explore a case of when a patient becomes severely depressed and suicidal and expresses this ideation during an o...
Source: PM and R - July 1, 2018 Category: Rehabilitation Authors: Elizabeth E. Sita, R. Brett Lloyd, Lynne C. Brady Wagner, Vu Q.C. Nguyen, Eric Swirsky, Debjani Mukherjee Tags: Ethical Legal Feature Source Type: research
